[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Scharfman H.E
Medical Uses of Semaglutide Semaglutide is primarily used in clinical settings for: * Type 2 diabetes management * Chronic weight management (obesity treatment support) * Cardiometabolic risk reduction * Insulin resistance research It is not just limited to diabetes care anymore
Beth Pyatak, PhD (USC), Barbara Turner, MD (USC), Eric Leven, MBA (Rip Road, Inc.) Community Partners: San Ysidro Health Funder: NCATS UL1 TR002550-01, Merck, NIMHD P50MD017344 Status: ACTIVE/2022-2024 ClinicalTrials.gov links: Hispanic adults are at greater risk for developing diabetes and diabetes-related complications and unfortunately, also experience more barriers to accessing health care
The eviCore clinical criteria for Wegovy as of 2026 are more restrictive than the FDA label and more restrictive than what Express Scripts publishes in formulary summaries
in the context of retatrutide, this effect is thought to be counterbalanced by concurrent GLP-1 and GIP receptor activity, though the precise interplay in humans remains an area of ongoing investigation
Many providers avoid combining GLP-1s with other appetite suppressants